CASCADE-LUNG: CANCER SCREENING ASSAY USING DELFI; A CLINICAL VALIDATION STUDY IN LUNG [PROTOCOL # DELFI-L201]

Set Your Location to See Relevant Information

Setting your location helps us to show you nearby providers and locations based on your healthcare needs.

CASCADE-LUNG: CANCER SCREENING ASSAY USING DELFI; A CLINICAL VALIDATION STUDY IN LUNG [PROTOCOL # DELFI-L201]

Study Details

BRIEF SUMMARY: CASCADE-LUNG is an event-driven, multisite, prospective, observational, blood specimen collection study in the elevated-risk lung cancer screening population. The primary objective is to determine the sensitivity and specificity of the Delfi Lung Cancer ScreeningTest (DLCST).

DETAILED DESCRIPTION: Participants will be enrolled into the DELFI-L201 study after informed consent and eligibility is confirmed. DELFI identifies circulating tumor DNA (ctDNA) to detect cancer. The study purpose is to validate the performance of the DELFI-based test for the detection of lung cancer among individuals eligible for routine lung cancer screening. Participants will have blood collected and medical record review at baseline and will have medical records reviews at two additional timepoints.

LEARN MORE

ClinicalTrials.gov NCT number
NCT05306288
Principal Investigator(s)
Michael Bernstein, MD
Contact
Carolina Garavito at 203-358-8879
or Officeofresearch@stamhealth.org

Location

  • SHMG- Pulmonary Associates
    29 Hospital Plaza
    Stamford, CT 06902

Our website uses cookies

This website uses cookies to give you the very best experience. Your continued use of this site is considered permission by you to use cookies in this manner. Please review our Privacy Policy and Terms of Use for more information about the data we collect and the types of cookies we use. Please note, if you link off our website to a 3rd party site of any kind, that website has its own terms and conditions.